Atlas Trials

Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia

Clinical trial NCT07139171 · RECRUITING

Trial details

NCT number
NCT07139171
Sponsor
Tianjin Anding Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Schizophrenia
Start date
2022-11-11
Primary completion
2025-10-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.